Innospec IOSP Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value

Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value at other companies

ZymeworksZYME

8—

KEE

Keel Infrastructure Corp. Common StockKEEL

$1.08+4.9%

BeldenBDC

$39.44+80.5%

CHE

ChemedCHE

85.8-25.1%

KEE

Keel Infrastructure Corp. Common StockKEEL

$0.72-35.7%

HTF

Heartflow, Inc. Common StockHTFL

15.9+124%

Other financials

Income statement

See full

Revenue$453.2M+2.8%

Gross profit$123.5M-1.3%

Operating income$36.5M-14.1%

Net income$30.4M-7.3%

EPS (diluted)$1.22-6.9%

Balance sheet

See full

Cash & equivalents$289.1M-3.6%

Total debt$50.6M+14.0%

Total equity$1.3B+6.7%

Total assets$1.8B+2.5%

Cash flow

See full

Operating cash flow$17.6M-37.8%

CapEx$8.9M+6.0%

Free cash flow$8.7M-56.3%

Valuation

See full

Market cap$2.05B-23.6%

Profitability

See full

Gross margin27.4%-1.3pp

Operating margin6.9%-2.6pp

Net margin6.4%—

FCF margin4.5%-1.1pp

Returns & leverage

See full

Return on equity8.8%—

Debt / equity0×0.0×

Current ratio3×+0.3×

Where this comes from

Reported directly by Innospec in its filing.

Tagged under the XBRL concept us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue.

The official record: Innospec’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innospec's sharebased compensation arrangement by sharebased payment award options vested weighted average grant date fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Innospec's sharebased compensation arrangement by sharebased payment award options vested weighted average grant date fair value?: Innospec (IOSP) reported sharebased compensation arrangement by sharebased payment award options vested weighted average grant date fair value of $92.70 in Q1 2026.